Using staining analysis of tissue from 101 glioma patients, the HSP90B1 protein was found to be significantly higher in tumor sections in GBM patients than in astrocytoma or oligodendrocytoma patients. This evidence concerns the gene HSP90B1 and astrocytoma (excluding glioblastoma).